No Data
Tian An Medicare's H1 Profit Surges as Revenue Grows
Tian An Health Group (00383) announced its interim results, with a net profit attributable to owners of 21.659 million Hong Kong dollars, an increase of about 15.53 times year-on-year.
Tian An China Investments Company Limited (00383) released its mid-term performance for 2024, with a total revenue of approximately 0.822 billion Hong Kong dollars, an increase of approximately...
In the first half of the year, Tian An China Investment Company Limited (00383.HK) had a net profit of 21.659 million Hong Kong dollars, an increase of about 15.5 times year-on-year.
On June 30, 2024, Tian An Health (00383.HK) announced that in the six months ended, the group recorded a total revenue of HKD 0.82 billion, an increase of approximately 7.47% year-on-year, and recorded a net profit attributable to owners of the company of HKD 21.659 million, an increase of approximately 15.5 times from the first half of 2023. This is mainly due to (i) the increase in revenue from the medical division as the epidemic prevention and control measures of the People's Republic of China are relaxed and economic and social activities resume; (ii) the decrease in healthcare consumables cost; (iii) the increase in bank deposit interest income; and (iv) the
TIANAN MEDICARE: UNAUDITED INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2024
Tian An Health InfoTech (00383.HK) plans to hold a board of directors meeting on August 2nd to approve its mid-term performance.
Tian An China Investments Company Limited (00383.HK) announced that the board of directors meeting will be held on August 2nd, 2024, Friday to approve the mid-term performance report from January 1st, 2024 to June 30th, 2024 inclusive and consider the payment of interim dividend (if any) of the company and its subsidiaries.
TIANAN MEDICARE: DATE OF BOARD MEETING
No Data
